| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 06/19/2007 | US7232906 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 06/19/2007 | US7232838 2-amino-4,5-trisubstituted thiazolyl derivatives |
| 06/19/2007 | US7232821 (2-((2-alkoxy)-phenyl) -cyclopent-1enyl) aromatic carbo and heterocyclic acid and derivatives |
| 06/19/2007 | US7232815 Dibenzo[b.f]oxazolo-azulines, -oxepines and -thiepines; antiinflammatories; analgesics |
| 06/19/2007 | US7232804 Use of KPV tripeptide for dermatological disorders |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2185826C Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/14/2007 | WO2007067629A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | WO2007067581A1 2-(n-methyl-propanamine)-3-(2-naphthol) thiophene, an impurity of duloxetine hydrochloride |
| 06/14/2007 | WO2007066148A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | WO2007066068A2 Calcium ion channel receptor antagonist |
| 06/14/2007 | WO2007065924A1 Bicyclic hξteroyclic compounds as antiinflammatory agents |
| 06/14/2007 | WO2007065888A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 06/14/2007 | WO2007065828A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | WO2007065821A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | WO2007065684A2 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 06/14/2007 | WO2007065683A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 06/14/2007 | WO2007065662A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | WO2007065482A1 Use of transferrins for treating destructive inflammation of mucous membrane |
| 06/14/2007 | WO2007065281A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 06/14/2007 | WO2007044050A3 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 06/14/2007 | WO2007042035A3 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 06/14/2007 | WO2006100213A8 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 06/14/2007 | US20070135523 Novel benzamidine derivatives having anti-inflammatory and immunosuppressive activity |
| 06/14/2007 | US20070135505 Aralkyl ester soft drugs |
| 06/14/2007 | US20070135502 Heterocyclic compounds and methods of use |
| 06/14/2007 | US20070135464 Antiinflammation agents |
| 06/14/2007 | US20070135458 6-Substituted pyrido-pyrimidines |
| 06/14/2007 | US20070135433 Imidazole derivatives as raf kinase inhibitors |
| 06/14/2007 | US20070135414 Tachykinin Antagonists |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/14/2007 | US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders |
| 06/14/2007 | US20070134720 Method of detecting effect of controlling synoviolin activity |
| 06/14/2007 | US20070134328 Oxymorphone controlled release formulations |
| 06/14/2007 | US20070134308 Non-steroidal anti-inflammatory drug formulations for topical applications to the skin |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134237 Human cytokine receptor |
| 06/14/2007 | US20070134164 Fentanyl composition for nasal administration |
| 06/14/2007 | US20070134153 Lipid-based drug delivery systems against parasitic infections |
| 06/14/2007 | CA2633107A1 Transdermal administration of active agents , in particular diclofenac |
| 06/14/2007 | CA2632531A1 Propionamide compounds as antiinflammatory agents |
| 06/14/2007 | CA2632109A1 Glucocorticoid receptor modulators as antiinflammatory agents |
| 06/14/2007 | CA2631809A1 Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents |
| 06/14/2007 | CA2631438A1 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | CA2631037A1 Bradykinin 1 receptor antagonists |
| 06/14/2007 | CA2630611A1 Aryl acetic acid and ester derivatives and their uses as antiinflammatory |
| 06/14/2007 | CA2629913A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 06/14/2007 | CA2629747A1 Bicyclic heteroyclic compounds as antiinflammatory agents |
| 06/14/2007 | CA2629608A1 Chromone derivatives useful as antagonists of vr1 receptors |
| 06/13/2007 | EP1794145A1 Pyrazole compounds useful in the treatment of inflammation |
| 06/13/2007 | EP1794130A1 Pyrazole compounds useful in the treatment of inflammation |
| 06/13/2007 | EP1793864A2 Method of treating an inflammatory disease by double stranded ribonucleic acid |
| 06/13/2007 | EP1793847A2 Use of microproteins as tryptase inhibitors |
| 06/13/2007 | EP1519908B1 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 06/13/2007 | EP1490065B1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 06/13/2007 | EP1456219B1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine A2a receptor agonist |
| 06/13/2007 | EP1455810B1 Pharmaceutical formulation comprising cyclosporin and use thereof |
| 06/13/2007 | EP1429795B1 Method for producing extracts of pelargonium sidoides and/or pelargonium reniforme |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1337512B1 (4-acylaminopiperidin-1-yl) acetamides as neurokinin antagonists |
| 06/13/2007 | EP1330425B1 C-nitroso compounds and use thereof |
| 06/13/2007 | EP1311303B1 Novel radiotherapeutic formulations containing 224 ra and a method for their production |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1000040B1 Il-5 inhibiting 6-azauracil derivatives |
| 06/13/2007 | EP0862630B1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1980927A Pyrazolopyridine derivatives |
| 06/13/2007 | CN1980886A Alpha-amino acid derivatives with antiinflammatory activity |
| 06/13/2007 | CN1980664A CRTH2 receptor ligands for therapeutic use |
| 06/13/2007 | CN1980658A Treatment of diseases using ICE inhibitors |
| 06/13/2007 | CN1978466A Transduction peptide-human brain-derived neurotrophic factor fusion protein and its use |
| 06/13/2007 | CN1977966A Ointment capable of expelling wind and eliminating stasis |
| 06/13/2007 | CN1977965A Chinese medicine composition for treating cold-damp back pain |
| 06/13/2007 | CN1977963A External Chinese medicine for treating ankylosing spondylitis |
| 06/13/2007 | CN1977923A Chinese medicine composition for treating arthralgia syndrome |
| 06/13/2007 | CN1977918A Venous preparation and its preparing method |
| 06/13/2007 | CN1977912A Chinese medicinal composition for treating cold |
| 06/13/2007 | CN1977899A Medicine for treating rheumatoid arthritis |
| 06/13/2007 | CN1977894A Medicinal composition with anti-inflammation effect and its preparing method |
| 06/13/2007 | CN1977892A Method for regulating baicalin and baicalein ratio in scutellariae root extract |
| 06/13/2007 | CN1977855A Medicinal composition containing mangiferin and its preparing method |
| 06/13/2007 | CN1977854A Use of total saponins of panax pseudoginseng and its preparation for SIRS supplementary treatment |
| 06/13/2007 | CN1977842A Combinations comprising dipeptidylpeptidase-IV inhibitors and antidiabetic agents |
| 06/13/2007 | CN1977837A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977836A Monoesters of probucol for the treatment of cardiovascular and inflammatory disease |
| 06/13/2007 | CN1977835A Monomer medicine for treating ankylosing spondylitis |
| 06/13/2007 | CN1977832A Novel sterile powder injection containing sodium new houttuyfonate orits receivable salt or derivative |
| 06/13/2007 | CN1321129C Inhibitors of caspases |
| 06/13/2007 | CN1320915C Strong-effect pain-removing liquor |
| 06/13/2007 | CN1320905C Inflammation-resisting pain-stopping preparation |
| 06/13/2007 | CN1320884C Muscle strong agent and anti-inflammatory agent |
| 06/13/2007 | CN1320883C Non injection medicament containing new sodium houttuyfonate |
| 06/13/2007 | CN1320880C Improved formulation for topical non-invasive application in vivo |